Skip to Main Content

Paper Details

Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics.
Neuro Oncol
36
2022
CNS tumor, CNS tumors, GBM, GBMs, methylation, tumor
Author NameAffiliation
Zied AbdullaevCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Drew PrattUniversity of Michigan ann arbor
Hye-Jung ChungCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Manoj TyagiCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Mark RaffeldCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Mark RaffeldCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Felix SahmInstitute of Pathology, University Hospital of Heidelberg
Felix SahmInstitute of Pathology, University Hospital of Heidelberg
Abigail K SuwalaInstitute of Pathology, University Hospital of Heidelberg
Andreas von DeimlingInstitute of Pathology, University Hospital of Heidelberg
Shirin KarimiUniversity of Toronto
Farshad NassiriUniversity of Toronto
Gelareh ZadehUniversity of Toronto
Eytan RuppinCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Martha QuezadoCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Martha QuezadoCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Kenneth AldapeCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Kenneth AldapeCenter for Cancer Research, National Cancer Institute, National Institutes of Health
  • 1 - 18

Datasets